Suppression of Frequent Ventricular Ectopy in a Patient with Hypertrophic Heart Disease with Ranolazine: A Case Report

BACKGROUND: Pro-arrhythmic concerns with most anti-arrhythmic agents in patients with significant left ventricular hypertrophy (LVH) limits options when anti-arrhythmic therapy is indicated. Ranolazine, an anti-anginal agent which inhibits late Na+ currents, indirectly causes a decrease in diastolic...

Descripción completa

Detalles Bibliográficos
Autores principales: Murdock, David K, Kaliebe, Jeffrey W
Formato: Texto
Lenguaje:English
Publicado: Indian Heart Rhythm Society 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083144/
https://www.ncbi.nlm.nih.gov/pubmed/21556158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083144/
https://www.ncbi.nlm.nih.gov/pubmed/21556158

Ejemplares similares